SU

278.6

+3.8%↑

BAS

52.71

-1.53%↓

REP

19.78

-5.63%↓

AM

327

+0.31%↑

EXE.US

95.75

-1.63%↓

SU

278.6

+3.8%↑

BAS

52.71

-1.53%↓

REP

19.78

-5.63%↓

AM

327

+0.31%↑

EXE.US

95.75

-1.63%↓

SU

278.6

+3.8%↑

BAS

52.71

-1.53%↓

REP

19.78

-5.63%↓

AM

327

+0.31%↑

EXE.US

95.75

-1.63%↓

SU

278.6

+3.8%↑

BAS

52.71

-1.53%↓

REP

19.78

-5.63%↓

AM

327

+0.31%↑

EXE.US

95.75

-1.63%↓

SU

278.6

+3.8%↑

BAS

52.71

-1.53%↓

REP

19.78

-5.63%↓

AM

327

+0.31%↑

EXE.US

95.75

-1.63%↓

Search

Eurofins Scientific SE

Затворен

69.98 1.13

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

69.86

Максимум

70.32

Ключови измерители

By Trading Economics

Приходи

105M

228M

Продажби

1.9B

3.7B

P/E

Средно за сектора

25.451

76.004

EPS

1.221

Дивидентна доходност

1.12

Марж на печалбата

6.2

Служители

65,694

EBITDA

285M

693M

Препоръки

By TipRanks

Препоръки

Купи

12-месечна прогноза

+10.75% upside

Дивиденти

By Dow Jones

Дивидентна доходност

Средно за сектора

1.12%

3.34%

Пазарни показатели

By TradingEconomics

Пазарна капитализация

-1.1B

11B

Предишно отваряне

68.85

Предишно затваряне

69.98

Техническа оценка

By Trading Central

Увереност

Weak Bearish Evidence

Eurofins Scientific SE Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

17.04.2026 г., 20:26 ч. UTC

Придобивния, сливания и поглъщания

UCB to Buy Neurona Therapeutics for Up to $1.15 Billion

17.04.2026 г., 18:15 ч. UTC

Значими събития в новините

Fed's Waller: Prolonged Iran Conflict Could Block Path to Rate Cuts

17.04.2026 г., 16:49 ч. UTC

Значими събития в новините

Week Ahead for FX, Bonds: U.S. Retail Sales, PMI -2-

18.04.2026 г., 01:00 ч. UTC

Значими събития в новините

As Economic Pressures Mount, Will Iran or the U.S. Blink First? -- WSJ

17.04.2026 г., 22:58 ч. UTC

Печалби

Grupo Aeroportuario Del Pacifico: Announces Filing of 2025 Annual Report and Form 20-F

17.04.2026 г., 21:32 ч. UTC

Пазарно говорене

Cerebras IPO Adds to Big Year For AI Firms Going Public -- Market Talk

17.04.2026 г., 21:22 ч. UTC

Пазарно говорене

Global Forex and Fixed Income Roundup: Market Talk

17.04.2026 г., 21:22 ч. UTC

Пазарно говорене

Moody's Downgrades Belgium to A1 -- Market Talk

17.04.2026 г., 20:52 ч. UTC

Печалби

Schwab Investors Get Spooked by JPMorgan's AI Strategy. The Big Worry Is Cash Sweeps. -- Barrons.com

17.04.2026 г., 20:50 ч. UTC

Пазарно говорене
Печалби
Придобивния, сливания и поглъщания

Tech, Media & Telecom Roundup: Market Talk

17.04.2026 г., 20:50 ч. UTC

Пазарно говорене

Basic Materials Roundup: Market Talk

17.04.2026 г., 20:29 ч. UTC

Печалби

These Stocks Are Today's Movers: Royal Caribbean, Dow Inc., Netflix, Intel, Albemarle, Autoliv, Alcoa, and More -- Barrons.com

17.04.2026 г., 20:11 ч. UTC

Придобивния, сливания и поглъщания

UCB to Buy Neurona Therapeutics for Up to $1.15B

17.04.2026 г., 19:34 ч. UTC

Пазарно говорене
Печалби
Придобивния, сливания и поглъщания

Global Equities Roundup: Market Talk

17.04.2026 г., 19:34 ч. UTC

Пазарно говорене
Печалби
Придобивния, сливания и поглъщания

Analysts See Netflix's Deal Commentary as Notable -- Market Talk

17.04.2026 г., 19:31 ч. UTC

Пазарно говорене
Значими събития в новините

Oil Futures Fall on Reopening of Strait of Hormuz -- Market Talk

17.04.2026 г., 19:26 ч. UTC

Пазарно говорене

U.S. Natural Gas Futures Edge Up -- Market Talk

17.04.2026 г., 19:21 ч. UTC

Пазарно говорене

Albemarle's Outperformance Belies Longer-Term Risks -- Market Talk

17.04.2026 г., 19:15 ч. UTC

Пазарно говорене

Danaher Seen Rebounding in 2H After Tools-Sector Weakness -- Market Talk

17.04.2026 г., 19:07 ч. UTC

Пазарно говорене

Danaher Faces Tough Comparative but Long‑Term Story Intact -- Market Talk

17.04.2026 г., 18:57 ч. UTC

Значими събития в новините

U.S. Stocks Surge on Hope Iran War Nearing End. Foreign Leaders Have a More Sober View. -- Barrons.com

17.04.2026 г., 18:53 ч. UTC

Придобивния, сливания и поглъщания

UCB Expects 2026 Adjusted Ebitda Growth in High Single-Digit to Mid-Teens Percentage Range at Constant Exchange Rates

17.04.2026 г., 18:53 ч. UTC

Придобивния, сливания и поглъщания

UCB 2026 Rev Guidance Unchanged

17.04.2026 г., 18:52 ч. UTC

Придобивния, сливания и поглъщания

UCB: Neurona Deal to Include $650M Upfront and Up to $500M in Potential Future Milestones

17.04.2026 г., 18:52 ч. UTC

Придобивния, сливания и поглъщания

UCB to Acquire Neurona Therapeutics for Up to $1.15B Including Potential Milestones

17.04.2026 г., 18:14 ч. UTC

Пазарно говорене
Значими събития в новините

Precious Metals Close Higher as Stronger Demand Eyed -- Market Talk

17.04.2026 г., 18:00 ч. UTC

Значими събития в новините

Fed's Waller: Quick Resolution in Middle East Could Allow Cuts Later This Year

17.04.2026 г., 18:00 ч. UTC

Значими събития в новините

Fed's Waller: Job Losses May Not Signal Recession Amid Demographic Changes

17.04.2026 г., 17:31 ч. UTC

Пазарно говорене
Значими събития в новините

U.S. Oil Rig Count Down By 1 at 410 -- Market Talk

17.04.2026 г., 17:26 ч. UTC

Пазарно говорене
Печалби

Netflix's Ability to Grow Engagement Seen as Up in the Air -- Market Talk

Сравнение с други в отрасъла

Ценова промяна

Eurofins Scientific SE Прогноза

Ценова цел

By TipRanks

10.75% нагоре

12-месечна прогноза

Среден 77.35 EUR  10.75%

Висок 81 EUR

Нисък 73.7 EUR

Според 2 анализатори от Wall Street, предложили 12-месечна ценова цел за Eurofins Scientific SE през последните три месеца.

Консенсусна оценка

By TipRanks

Купи

2 ratings

1

Купи

1

Задържане

0

Продай

Техническа оценка

By Trading Central

54.22 / 56.82Подкрепа & съпротива

Краткосрочен план

Weak Bearish Evidence

Средносрочен план

Strong Bullish Evidence

Дългосрочен план

Bullish Evidence

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

$

Относно Eurofins Scientific SE

Eurofins Scientific SE, together with its subsidiaries, provides various analytical testing and laboratory services worldwide. The company offers a portfolio of various analytical methods and tests to evaluate the safety, identity, composition, authenticity, origin, traceability, and purity of various products. It provides services such as agroscience, including biological assessment, consumer and human, and environmental safety, product chemistry, regulatory consultancy, and seed services; agro testing; assurance, such as product inspection, auditing, certification, training and consultation of food, consumer products, healthcare and cosmetics, and food supplements; biopharma, and clinical diagnostics. In addition, the company offers consumer product testing, which include sustainability, expert services and regulatory, consumer research and sensory evaluation, audits, testing, certifications and approvals, inspections, and training courses for various industries; cosmetics and personal care; environment testing, including water, air, soil, waste, and other products testing; and food and feed testing that include allergen, GMO, grain, meat, nano material, pesticides, and residual DNA testing. Further, it offers audit and certification, training and consulting; food irradiation and labelling, heavy metals, carbohydrates, radioactivity, nutritional analysis, microbiolody, and testing for persistent organic pollutants, veterinary drug residue, dioxins and organic contaminants, pesticides, mycotoxins, and vitamins, as well as analyses for genetic modifications. Additionally, the company provides forensic, genomic, maritime, materials and engineering, REACH, and other services. The company was founded in 1987 and is headquartered in Luxembourg City, Luxembourg.
help-icon Live chat